Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

NDORMS PhD student Akira Wiberg won the main prize of this year's Max Perutz Science Writing Award. The MRC-funded student received the first prize of £1,500 for his article: "Getting on your nerves", at the awards ceremony on 15 October.

Horizontal portrait of Akira Wiberg

Award-winner Akira Wiberg said: "I'm utterly delighted. It was unexpected so a very pleasant surprise and I'm very pleased that the disease I'm studying - carpal tunnel syndrome - has got a bit of publicity today, because it's very debilitating and important for society. I'm hoping to tread a career as a surgeon scientist. I'm currently a plastic surgery trainee but I want to carry on doing my clinical work alongside research and I think communicating my research with the public is very important. This is my first step in doing that."

Akira's research focusses on understanding the genetic basis of Carpal Tunnel Syndrome, and ultimately shed light on the pathophysiology of nerve injury through compression. The prevalence of the condition in the UK is 7–16%.

The awards were announced by the MRC's Executive Chair Professor Fiona Watt, who chaired the judging panel, and fellow judge Andy Ridgeway, journalist and Senior Lecturer in Science Communication at the University of the West of England in Bristol.

Fiona said: “This is the second year that I have chaired the judging panel of our Max Perutz Award. It is a really enjoyable experience. From this year’s set of 116 entries, we shortlisted 12 outstanding writers. Their articles represent the fantastic breadth of research we fund – from discovery research to clinical studies and development of new technologies. Topics include disease prevention, precision medicine and new ways to treat mental health conditions and tackle antimicrobial resistance.

"Using conversational language, relatable anecdotes and personal experiences, the writers grab the reader’s attention, explaining simply and clearly why their research matters. I’m proud to say that previous winners have gone on to win national science writing awards, give TED talks and become BBC presenters. Encouraging our researchers to make their science accessible to non-scientists is more important than ever to help us secure public and government support for life-changing research. For many entrants this was their first step along that journey – I wish them every success in future."

Dr Roger Highfield, MRC Council member and Science Director of the Science Museum Group, was the third member of the judging panel. Commenting on the importance of good science communication he said: “We need to build public acceptance and enthusiasm for what scientists do if research is to thrive. I really enjoyed judging the Max Perutz Award, which provides a panoramic glimpse of the epic range of MRC-funded research and encourages embryonic writing talent.

“This research was funded by the public, so we have to explain how the money has been spent and why. It is critical that young scientists learn how to write in a way that can grab the interest of non-specialist so they have the opportunity to explain why their work really matters in a way that any taxpayer can understand.”

Before the ceremony the shortlisted entrants had the chance to attend a science writing masterclass led by Dr Claire Ainsworth, freelance journalist and science writer. During the afternoon session, the shortlisters learnt about the principles of effective popular-style science writing and tried their hand at editing each other’s articles.

The award is named in honour of one of the UK’s most outstanding scientists and communicators, Dr Max Perutz. Max, who died in 2002, was awarded the 1962 Nobel Prize in Chemistry and was the founder and first chairman of the MRC Laboratory of Molecular Biology (LMB) in Cambridge. Max was also a keen and talented communicator who inspired countless students to use everyday language to share their research with the people whose lives are improved by their work.

This year's shortlisted articles are now published (PDF, 1.35MB). Read Akira's winning article on our blog.

Max Perutz Science Writing Award 2019

Similar stories

T-cell coreceptors are well endowed—with kinases!

The kinase occupancy of CD4 and CD8 coreceptors is high, according to a new study published in PNAS.

Two prestigious Hunterian Professorships awarded to NDORMS researchers

Conrad Harrison and Tom Layton have both been awarded Hunterian Professorships for 2022 by the Royal College of Surgeons of England

Dr Alex Clarke wins Emerging Leaders Prize for lupus research

Alex is one of three exceptional lupus researchers that have been announced as winners of the Medical Research Foundation’s sixth Emerging Leaders Prize.

Adalimumab is found to be a cost-effective treatment for early-stage Dupuytren’s disease

Researchers at the Kennedy Institute of Rheumatology and Oxford Population Health’s Health Economics Research Centre have found that anti-TNF treatment (adalimumab) is likely to be a cost-effective treatment for people affected by early-stage Dupuytren’s disease.

Patients like me

What can patients learn from the experiences of people like them who’ve already had a hip replacement? A new tool called ‘Patients like me’ helps answer some of the questions about pain, complications and how long the prosthesis might last.

Study reveals new evidence on rare blood-clotting condition after covid-19 vaccination

Researchers from NDORMS at the University of Oxford have investigated claims that some adenovirus-based COVID-19 vaccines increase the risk of rare blood clots compared to their mRNA-based counterparts.